Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome. - Wikidata - awgldk - TriplyDB

Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.

Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.

http://www.wikidata.org/entity/Q33429893

about

Activated platelet-derived and leukocyte-derived circulating microparticles and the risk of thrombosis in heparin-induced thrombocytopenia: A role for pf4-bearing microparticles?Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.

P2860

Q33438155-C01FC75D-684A-464C-9AA2-9DFD21BB2A6B Q33440890-F7801B05-878B-40EA-A853-B0AAD7775B4A

P2860

Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.

http://www.wikidata.org/entity/Q33429893

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@ast

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@en

type

label

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@ast

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@en

prefLabel

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@ast

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@en

P1433

Q33429893-61C6395A-9799-4D5E-8350-C3CEAFDDB939

P1476

Q33429893-509B9531-0F47-4AF2-8D1C-659CAB7D5F2A

P2093

Q33429893-25EF76C9-B15A-4427-A17E-83B0AC1826FB

Q33429893-37F0D987-8981-4B43-8190-11A54BAB4D18

Q33429893-403E2637-D7C4-47F9-9458-CEF4D44C5F42

Q33429893-639B00C9-7373-4B1E-88C8-36F5EC18F45A

Q33429893-861D6077-9BB8-439D-838E-970EAA652933

Q33429893-EAB13960-7712-4FF7-BDFC-892336B51E74

Q33429893-F74239E5-E954-40C4-BB36-074F6D93A63B

Q33429893-FD5B1CB0-3823-41E2-BBE2-048989F69412

P2860

Q33429893-0ED4A85D-1DB2-4707-84B3-A0334ACA1E3D

Q33429893-21245188-C02B-4B49-92F1-36292040AE3A

Q33429893-3E268DC8-2DAD-4FD4-91DF-5368115846E6

Q33429893-4B13A7CB-C71C-4712-9214-58A59BFAA70D

Q33429893-53CC86D0-C176-4DB3-998B-E74594207A4A

Q33429893-5EE9462F-EE69-47A0-9239-8CB622052042

Q33429893-6AE836A4-720C-4AC9-B560-819E19475267

Q33429893-70EA48FD-8190-4FF0-8C54-172CA01D30E9

Q33429893-7403FCEE-97D5-4869-A577-E65E302DEF4B

Q33429893-77E2F970-5A7D-474B-A66D-1F3E7597CC47

P31

Q33429893-F920875F-410D-4E07-9DC2-DFE85752DED6

P356

Q33429893-A5A1CCA3-C94B-4EC4-BE3F-95E538777F32

P577

Q33429893-24E86F4E-B63E-4F52-9814-F933BBC6858D

P698

Q33429893-793E26D8-ABFB-495D-BFE5-968F6B340ACF

P356

P1433

Cytometry Part B: Clinical Cytometry

P1476

Evaluation of flow cytometric ...... unoassay and clinical outcome.

@en

P2093

Adrienne Kerényi

http://www.w3.org/2001/XMLSchema#string

Béla Nagy

http://www.w3.org/2001/XMLSchema#string

Ildikó Beke Debreceni

http://www.w3.org/2001/XMLSchema#string

János Kappelmayer

http://www.w3.org/2001/XMLSchema#string

László Muszbek

http://www.w3.org/2001/XMLSchema#string

Péter Ilonczai

http://www.w3.org/2001/XMLSchema#string

Zsolt Oláh

http://www.w3.org/2001/XMLSchema#string

Zsuzsanna Bereczky

http://www.w3.org/2001/XMLSchema#string

P2860

Laboratory diagnosis of heparin-induced thrombocytopenia: advantages of a functional flow cytometric test in comparison to the heparin-induced platelet-activation test.

Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia.

New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.

What is the potential for overdiagnosis of heparin-induced thrombocytopenia?

Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.

A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia.

P31

scholarly article

P356

10.1002/CYTO.B.21362

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26860978

http://www.w3.org/2001/XMLSchema#string